As a member of the Investment team, Emma supports KTN’s early stage investment activities, including investment readiness and pitch training programmes. She helps companies to evaluate their business, commercial and to-market plans and links them into the relevant support, funding and investment networks.

With a PhD in tumour immunology, Emma’s background encompasses a range of health applications, including vaccines, medical devices, and mental health programmes. Prior to joining KTN, she was Head of Business Development at The Pirbright Institute.

Emma is also a Director of the Cyber Security Academic Startup Accelerator Programme Now in its fourth year, CyberASAP provides academic teams with vital tools and skills to help them take their cyber security ideas from the lab to the market.

Contact Emma Fadlon